Pulmonary & Nasal Delivery Designed for Inhalation
Summary: From the top industry partner for development, launch and supply of new treatments, Catalent offers integrated solutions for pulmonary and nasal delivery with significant capacity in North America. Our in-house capabilities span clinical and commercial scale manufacturing for DPIs, unit-dose, bi-dose and multi-dose nasal sprays. With more than 30 years of experience in supporting the development of inhaled and nasal products, from formulation feasibility, process development, performance characterization and clinical supply to commercial filling, packaging and final product testing, our team of experts provide scalable, reliable solutions to support your molecule at any stage in development.